08.04.14
A higher level of accuracy will drive decreased costs for the healthcare system, benefiting us all. Entrepreneurs on the cutting edge of the market will make new molecular diagnostics a reality by improving outcomes and reducing healthcare costs, which along with safety and efficacy, are becoming part of the true value proposition for savvy medtech firms. There is profit in providing improved financial outcomes in healthcare. How will you identify those opportunities?
References
References
- EvaluateMedtech, World Preview 2013, Outlook to 2018, The Future of Medtech, September 2013
- Molecular Diagnostics Market by Application Global Forecasts to 2018, www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-m33.html?gclid=CJj61YrHs78CFW4Q7Aod-BcAwA
- http://aje.oxfordjournals.org/content/157/11/1015.full.pdf+html
- Introduction to Molecular Diagnostic, http://advameddx.org/download/files/AdvaMedDx_DxInsights_FINAL(2).pdf
- AAOS Now, May 2011, www.aaos.org/news/aaosnow/may11/research3.asp
- J. Clin. Microbiol. February 2003 vol. 41 no. 2 531-534
- http://pitchengine.com/pitches/ 39afc905-b545-4255-9700-68eea57780c1
- Ibid
- Ibid